Vicore Pharma Holding AB (OSTO:VICO BTA) Operating Cash Flow per Share : kr-24.11 (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Vicore Pharma Holding AB Operating Cash Flow per Share?

Vicore Pharma Holding AB's operating cash flow per share for the three months ended in Mar. 2025 was kr-7.57. Vicore Pharma Holding AB's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was kr-24.11.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 31.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 5.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -28.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Vicore Pharma Holding AB's Operating Cash Flow per Share or its related term are showing as below:

OSTO:VICO BTA' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -113.2 Med: -32.6 Max: 31.2
Current: 31.2

During the past 12 years, Vicore Pharma Holding AB's highest 3-Year average Operating Cash Flow per Share Growth Rate was 31.20% per year. The lowest was -113.20% per year. And the median was -32.60% per year.

OSTO:VICO BTA's 3-Year OCF Growth Rate is ranked better than
74.15% of 1203 companies
in the Biotechnology industry
Industry Median: 9.4 vs OSTO:VICO BTA: 31.20

Vicore Pharma Holding AB Operating Cash Flow per Share Historical Data

The historical data trend for Vicore Pharma Holding AB's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicore Pharma Holding AB Operating Cash Flow per Share Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-10.55

-23.32

-26.38

-21.95

-14.51

Vicore Pharma Holding AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															2.03	-4.36	-7.68	-4.50	-7.57

Competitive Comparison of Vicore Pharma Holding AB's Operating Cash Flow per Share

For the Biotechnology subindustry, Vicore Pharma Holding AB's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vicore Pharma Holding AB's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vicore Pharma Holding AB's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vicore Pharma Holding AB's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Vicore Pharma Holding AB Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Vicore Pharma Holding AB's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-164.946	/	11.369
	=	-14.51

Vicore Pharma Holding AB's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-86.113	/	11.369
	=	-7.57

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-24.11

Vicore Pharma Holding AB Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Vicore Pharma Holding AB's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicore Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vicore Pharma Holding AB (OSTO:VICO BTA) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

VICO:Sweden

Address

Kornhamnstorg 53, Stockholm, SWE, 111 27

Website

https://www.vicorepharma.com

Vicore Pharma Holding AB is a clinical-stage pharmaceutical company focused on severe lung diseases. The company is establishing a portfolio in respiratory diseases, including idiopathic pulmonary fibrosis (IPF). Its C21 is a small molecule angiotensin II type 2 receptor agonist (ATRAG) currently in phase 2b development for IPF. The company also has an investigational medical device in clinical development, namely, Almee, which is a digital therapeutic leveraging cognitive behavioral therapy created to address the psychological impact of living with pulmonary fibrosis.

Vicore Pharma Holding AB Headlines

No Headlines